Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2020

Jul 22, 2020

32044_dirs_2020-07-21_a5d9ac4f-3826-4aa2-a260-a0b0f44f0b98.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2020-07-17

Reporting Person: Sabzevari Helen (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-17 Common Stock M 25000 Acquired 414365 Direct
2020-07-20 Common Stock S 12220 $4.58 Disposed 402145 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-17 Restricted Stock Units $ M 25000 Disposed Common Stock (25000) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Precigen common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.

F3: The restricted stock units were granted on March 28, 2018 and the remaining restricted stock units vest on July 17, 2021.